ArticleBone marrow transplantation2021

Maintenance sorafenib is superior to prophylactic donor lymphocyte infusion at improving the prognosis of acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication after allogeneic hematopoietic stem cell transplantation.

Jimin Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.